JNJ vs NVDA: Which Is the Better Buy?
Side-by-side comparison of Johnson & Johnson and NVIDIA Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-09-26.
Johnson & Johnson · Healthcare
$270.68
+5.7% upside to fair value
Med Conviction
Grade C
High Quality
VS
NVIDIA Corporation · Technology
$225.07
+45.0% upside to fair value
Med Conviction
Grade B
High Quality
QuantHub Verdict
NVDA has more upside to fair value
(+45.0%).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
JNJ |
NVDA |
| Current Price |
$270.68 |
$225.07 |
| Fair Value Estimate |
$286.05 |
$326.35 |
| Upside to Fair Value |
+5.7%
|
+45.0%
|
| Market Cap |
$652.3B |
$5,451.4B |
| Forward P/E |
—
|
—
|
| EV / EBITDA |
20.2x
|
23.4x
|
| Price / Sales |
6.7x
|
18.0x
|
| Price / FCF |
35.3x
|
42.9x
|
| Revenue Growth YoY |
+6.6%
|
+105.9%
|
| Gross Margin |
67.9%
|
74.7%
|
| Operating Margin |
26.8%
|
65.2%
|
| Return on Equity |
25.7%
|
110.1%
|
| Dividend Yield |
1.95% |
0.23% |
| FCF Yield |
2.83%
|
2.33%
|
| Analyst Consensus |
Buy
|
Strong Buy
|
Investment Thesis
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:…
NVIDIA designs the accelerated computing platforms at the center of the AI buildout, spanning data center GPUs, Mellanox networking, AI enterprise software, gaming GeForce GPUs, professional visualization, and automotive platforms, with 42,000 employees and a $5.45 trillion market capitalization. Business quality is exceptional on the fundamentals: TTM gross margin of 74.7%, TTM operating margin …
Accumulation Zones
| Metric |
JNJ |
NVDA |
| Zone Low |
$214.54 |
$244.76 |
| Zone High |
$243.14 |
$277.40 |
| In Buy Zone? |
No
|
Yes
|